
aTyr Pharma (ATYR) shares remain in focus on Thursday after controversial American investor Martin Shkreli revealed a short position against the biotherapeutics firm.
According to Shkreli, investors should pull out of aTyr shares at current levels as they could crash as much as 80% within the next six weeks.